Retinoblastoma-like protein 1

Retinoblastoma-like protein 1 (RBL1), also known as p107, is a tumor suppressor protein that plays a crucial role in regulating cell cycle progression and preventing the development of cancer. It is a member of the retinoblastoma protein (Rb) family, which also includes Rb protein and retinoblastoma-like protein 2 (RBL2 or p130). RBL1 is encoded by the RBL1 gene located on chromosome 20q11.2.

Structure and Function

RBL1 consists of several functional domains that contribute to its tumor suppressor activity. It contains a pocket domain, similar to Rb protein, which interacts with various cellular proteins involved in cell cycle regulation. The pocket domain of RBL1 binds to E2F transcription factors, preventing their activation and subsequent progression of the cell cycle. Additionally, RBL1 has a C-terminal domain that interacts with other proteins involved in transcriptional regulation.

The main function of RBL1 is to inhibit cell cycle progression by preventing the activation of E2F transcription factors. E2F transcription factors are essential for the expression of genes required for cell cycle progression. By binding to E2F, RBL1 blocks their ability to activate target genes, thereby halting cell cycle progression and promoting cell cycle arrest. This mechanism ensures that cells do not divide uncontrollably and helps prevent the development of cancer.

Role in Cancer

Mutations or dysregulation of RBL1 can lead to the loss of its tumor suppressor function, contributing to the development of various types of cancer. Studies have shown that RBL1 is frequently inactivated or downregulated in several human cancers, including lung, breast, and bladder cancer. Loss of RBL1 function allows E2F transcription factors to become active, leading to uncontrolled cell proliferation and tumor formation.

Clinical Significance

The dysregulation of RBL1 has important clinical implications. Researchers have identified RBL1 as a potential prognostic marker and therapeutic target in various cancers. Understanding the molecular mechanisms underlying RBL1 function and its role in cancer development can help in the development of targeted therapies for these diseases.

See Also

• Retinoblastoma protein
• Retinoblastoma-like protein 2
• Tumor suppressor protein
• Cell cycle regulation

References

1. Harbour JW. The Retinoblastoma Protein Pathway in Cell Cycle Control and Cancer. Exp Cell Res. 2001;264(2):149-156. doi:10.1006/excr.2000.5130 2. Cobrinik D. Pocket proteins and cell cycle control. Oncogene. 2005;24(17):2796-2809. doi:10.1038/sj.onc.1208619